FDA Import Refusal SCS-1543216-9/22/1 — NANDINI K N

NANDINI K N — FEI 3038493966

The FDA refused shipment SCS-1543216-9/22/1 from NANDINI K N (India) on Jul 30, 2025. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 1 other import refusal on record.